Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190223042808N1Phase 2Completed
Phase 2, open-label, single-arm trial of metoclopramide in nausea ((none)), sponsored by Islamic Azad University. Primary endpoints: Prevention of nausea reflex during molding and Change in nausea reflex intensity score. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190223042808N1.